In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Mersana Therapeutics Inc’s stock clocked out at $1.88, up 2.73% from its previous closing price of $1.83. In other words, the price has increased by $2.73 from its previous closing price. On the day, 1.28 million shares were traded. MRSN stock price reached its highest trading level at $1.97 during the session, while it also had its lowest trading level at $1.83.
Ratios:
To gain a deeper understanding of MRSN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.51 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 0.87.
On February 29, 2024, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $7.
Guggenheim Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 16 ’24 when Protopapas Anna sold 29,399 shares for $2.71 per share. The transaction valued at 79,671 led to the insider holds 125,153 shares of the business.
Lowinger Timothy B sold 10,409 shares of MRSN for $28,208 on Jan 16 ’24. The SVP, Chief Sci.&Tech. Officer now owns 199,329 shares after completing the transaction at $2.71 per share. On Jan 16 ’24, another insider, DeSchuytner Brian, who serves as the SVP, COO & CFO of the company, sold 9,327 shares for $2.71 each. As a result, the insider received 25,276 and left with 54,511 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 230038672 and an Enterprise Value of 80608120. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.01 while its Price-to-Book (P/B) ratio in mrq is 8.22. Its current Enterprise Value per Revenue stands at 2.105 whereas that against EBITDA is -0.608.
Stock Price History:
The Beta on a monthly basis for MRSN is 1.52, which has changed by -0.49326146 over the last 52 weeks, in comparison to a change of 0.2553556 over the same period for the S&P500. Over the past 52 weeks, MRSN has reached a high of $6.28, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is -24.52%, while the 200-Day Moving Average is calculated to be -31.01%.
Shares Statistics:
It appears that MRSN traded 1.66M shares on average per day over the past three months and 1056530 shares per day over the past ten days. A total of 120.71M shares are outstanding, with a floating share count of 91.93M. Insiders hold about 24.87% of the company’s shares, while institutions hold 74.73% stake in the company. Shares short for MRSN as of 1718323200 were 10452033 with a Short Ratio of 6.30, compared to 1715731200 on 8989035. Therefore, it implies a Short% of Shares Outstanding of 10452033 and a Short% of Float of 11.2399995.
